Singapore markets closed

Amneal Pharmaceuticals, Inc. (AMRX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
5.94+0.07 (+1.19%)
At close: 04:00PM EDT
5.86 -0.08 (-1.35%)
After hours: 07:00PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-83,993
-83,993
-129,986
10,624
91,059
Depreciation & amortisation
229,400
229,400
240,175
233,406
235,387
Deferred income taxes
-
-
-
0
0
Stock-based compensation
26,822
26,822
31,847
28,412
20,750
Change in working capital
-47,186
-47,186
-59,945
-133,593
-61,318
Accounts receivable
126,289
126,289
-79,717
-23,621
16,787
Inventory
-126,182
-126,182
-102,396
-49,015
-113,782
Accounts payable
-94,446
-94,446
109,568
-43,932
307
Other working capital
276,388
276,388
-25,495
189,181
312,815
Other non-cash items
44,413
44,413
17,445
15,188
19,960
Net cash provided by operating activities
345,577
345,577
65,100
241,820
379,001
Cash flows from investing activities
Investments in property, plant and equipment
-69,189
-69,189
-90,595
-52,639
-66,186
Acquisitions, net
0
0
-84,714
-146,543
-251,360
Other investing activities
-
-
1,000
5,000
-
Net cash used for investing activities
-69,189
-69,189
-174,309
-194,182
-317,546
Cash flows from financing activities
Debt repayment
-414,080
-414,080
-123,272
-79,179
-37,012
Dividends paid
0
-
-
-
-
Other financing activities
-235,676
-235,676
-69,010
-59,796
-11,502
Net cash used provided by (used for) financing activities
-212,573
-212,573
-106,620
-138,122
131,807
Net change in cash
63,880
63,880
-221,512
-90,382
194,299
Cash at beginning of period
35,227
35,227
256,739
347,121
152,822
Cash at end of period
99,107
99,107
35,227
256,739
347,121
Free cash flow
Operating cash flow
345,577
345,577
65,100
241,820
379,001
Capital expenditure
-69,189
-69,189
-90,595
-52,639
-66,186
Free cash flow
276,388
276,388
-25,495
189,181
312,815